Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1452681Generated: November 1, 2026

methyl (4S)-3-({[3-(4-[3-(acetylamino)phenyl]-3,6-dihydro-1(2H)-pyridinyl)propyl]amino}carbonyl)-4-(3,4-difluorophenyl)-6-(methoxymethyl)-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate → Snap-7941

https://huagongshe.com/reaction/1452681

Reaction equation

Participants

RoleNameHCIDCharge
Reactantmethyl (4S)-3-({[3-(4-[3-(acetylamino)phenyl]-3,6-dihydro-1(2H)-pyridinyl)propyl]amino}carbonyl)-4-(3,4-difluorophenyl)-6-(methoxymethyl)-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylateHCID 69523367—
CatalystPalladiumHCID 23938—
SolventMethanolHCID 887—
ProductSnap-7941HCID 11520239—

Reaction Steps

Methyl (4S)-3-({[3-(4-[3-(acetylamino)phenyl]-3,6-dihydro-1(2H)-pyridinyl)propyl]amino}carbonyl)-4-(3,4-difluorophenyl)-6-(methoxymethyl)-2-oxo-1,2,3,4-tetrahydro-5-pyrimidine carboxylate was tritiated (Amersham) using the described cold method (H2, balloon method, Methanol, Pd/C, overnight) to give the tritiated methyl (4S)-3-{[(3-{4-[3-(acetylamino)phenyl]-1-piperidinyl}propyl)amino]carbonyl}-4-(3,4-difluorophenyl)-6-(methoxymethyl)-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate ((+)−isomer), which in turn, was used as a radioligand in the MCH pharmacological assays.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07473698B2
Source datasetuspto-grants-2009_01
ORD IDord-feb29517c1b9455490fa2594cdeb21eb
Source noteuspto-grants-2009_01